Roivant Sciences Ltd
NASDAQ:ROIV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
BM |
|
O
|
Obayashi Corp
OTC:OBYCF
|
JP |
|
S
|
Spenda Ltd
OTC:CROTF
|
AU |
|
Elysee Development Corp
XTSX:ELC
|
CA |
|
Jupiter Energy Ltd
ASX:JPR
|
AU |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
ASML Holding NV
MIL:1ASML
|
NL |
|
B
|
BW Energy Ltd
OSE:BWE
|
BM |
|
China Natural Resources Inc
NASDAQ:CHNR
|
HK |
|
F
|
First Pacific Co Ltd
OTC:FPAFF
|
HK |
|
Prophecy International Holdings Ltd
ASX:PRO
|
AU |
|
O
|
Ormat Technologies Inc
LSE:0KDH
|
US |
|
Rieter Holding AG
SIX:RIEN
|
CH |
|
Orgenesis Inc
OTC:ORGS
|
US |
|
Chordia Food Products Ltd
BSE:519475
|
IN |
Wall St Price Targets
ROIV Price Targets Summary
Roivant Sciences Ltd
According to Wall Street analysts, the average 1-year price target for
ROIV is 41.82 USD with a low forecast of 36.14 USD and a high forecast of 52.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ROIV's stock price target?
Price Target
41.82
USD
According to Wall Street analysts, the average 1-year price target for
ROIV is 41.82 USD with a low forecast of 36.14 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Roivant Sciences Ltd?
Projected CAGR
169%
Over the last 5 years, the compound annual growth rate for Revenue has been -19%. The projected CAGR for the next 7 years is 169%.
What is the Gross Profit forecast for Roivant Sciences Ltd?
Projected CAGR
169%
Over the last 5 years, the compound annual growth rate for Gross Profit has been -20%. The projected CAGR for the next 7 years is 169%.